Trial Design Studio

CDOS-512 · Draft Protocol

Step 1 of 7 — AI co-designing your study.

Design progress14%

Study basics

High-level identifiers and therapeutic area.

Study code

Sponsor

Study title

Indication

Therapeutic area

Phase

Regulatory pathway

Based on Atopic Dermatitis precedent (12 prior Phase II studies), AI recommends a 16-week primary readout with EASI-75 as the regulatory anchor endpoint.

Step 1 of 7 · Basics